The giants of Johnson & Johnson, hygiene and pharmacy have sunk on Friday 10.4% Wall Street, where he came from a higher percentage will drop for more than ten years. All this when Reuters released the drug I knew their talc powder for babies contained asbestos.
J & J has encountered some 6,000 cases who claim that their baby and shower products produce ovarian cancer.
The drop in shares was dropped $ 24 billion worth of the company and turned its stake into the largest drawstring of the Dow Jones and S & P 500 indexes.
According to Reuters, J & J was aware of its small asbestos content in its products since 1971, as is evident in a number of internal reports and other confidential medical records of the medical profession.
J & J was aware of its small asbestos content in its products since 1971
The report also found that the company had commissioned and paid for studies carried out in its Baby Powder franchise hired a ghostwriter to write an article that presented the results in the journal.
The company, in turn, says that history is "Absurd conspiracy theory"Since J & J's regulators and independent experts have used all available methods to check whether J & J is asbestos and all these methods have shown that cosmetic talc is free of asbestos."
In Argentina, it is not selling Johnson & Johnson to marry a fatal milestone sentence
J & J has encountered some 10,000 cases who claim that their products Baby Powder and Shower to Shower cause ovarian cancer. Products have also been linked mesothelioma, a rare and lethal form of cancer that affects the delicate tissue of the lining of the body cavities.
A few months ago, the United States' highest health authority (FDA, English abbreviated name) a study was carried out that sampled the product where it did not detect the presence of asbestos. This, however, did not prevent the Saint Louis Missouri Jury from decreasing the company's $ 4.96 billion for 22 women and their families who had made him ill after using the baby product in July. The company complained about the decision.
Last year, the Los Angeles court also condemned the multinational to pay $ 417 million to a woman who developed ovarian cancer when using talc powder for years. The belief was that Johnson & Johnson had not warned enough about the cancer risk due to the use of the products. The company received a complaint against this decision. "Science was set," said pharmaceutical Williams lawyer Bart Williams. On Wall Street on Friday, skepticism of investors prevailed.
Source: La Vanguardia and El País